Abstract Although studies have shown beneficial effects of the phytoestrogen genistein on reducing ovarian cancer risk, little is known at molecular level regarding how inhibits growth, with estrogen receptor beta (ERb), a hormone-regulated transcription factor, receiving bulk attention. When endogenous and exogenous ligands engage ERb, binds to regulatory regions in genome as enhancers, where ...